SCHEMBL8667992

SCHEMBL8667992

[CH](Cc1ccncc1)c1ccc2ccccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RELA Q04206 1/20 0.43
CYP1A2 P05177 4/20 0.41
CYP1A1 P04798 2/20 0.41
CYP1B1 Q16678 2/20 0.41
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
RAB9A P51151 2/20 0.40
CHEK1 O14757 1/20 0.39
PTGS1 P23219 1/20 0.39
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
MAPK9 P45984 2/20 0.38
MAPK10 P53779 2/20 0.38
MAPK8 P45983 1/20 0.38
CYP19A1 P11511 1/20 0.37
GLA P06280 1/20 0.37
MAPT P10636 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NQO2 P16083 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8204171 0.85 RELA (0.53) RELACYP1A2ALDH1A1KDM4EL3MBTL1
SCHEMBL8668276 0.82 CYP2D6 (0.48) RELACYP1A2CYP1A1CYP1B1CYP3A4
SCHEMBL8668861 0.82 RAB9A (0.51) RELACYP1A2ALDH1A1KDM4EL3MBTL1
SCHEMBL5966235 0.77 CYP1A2 (0.46) CYP1A2ALDH1A1CYP3A4CYP2D6CYP19A1
SCHEMBL8202649 0.75 CYP3A4 (0.48) CYP1A2ALDH1A1KDM4ERAB9ACYP3A4
SCHEMBL8670948 0.75 SMN1; SMN2 (0.46) RELAALDH1A1KDM4EL3MBTL1RAB9A
SCHEMBL5812504 0.75 RELA (0.42) RELACYP1A2ALDH1A1KDM4EL3MBTL1
SCHEMBL4800219 0.74 CYP1A1 (0.49) RELACYP1A2CYP1A1CYP1B1ALDH1A1
SCHEMBL2604933 0.74 RELA (0.70) RELACYP1A2CYP1A1CYP1B1ALDH1A1
SCHEMBL3163586 0.74 RELA (0.70) RELACYP1A2CYP1A1CYP1B1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2825157-B1 AMINOACID LIPIDS MERCK PATENT GMBH (DE) 2018-09-05 EP disclosed
US-9796666-B2 Aminoacid lipids MERCK PATENT GMBH (DE) 2017-10-24 US disclosed
US-20150030670-A1 AMINOACID LIPIDS MERCK PATENT GMBH (DE) 2015-01-29 US disclosed
EP-2825157-A1 AMINOACID LIPIDS Merck Patent GmbH (DE) 2015-01-21 EP disclosed
WO-2013135360-A1 AMINOACID LIPIDS MERCK PATENT GMBH (DE) 2013-09-19 WO disclosed
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150030670-A1 AMINOACID LIPIDS PHOSPHO1, SLC7A5, SLC1A5 RELA 4786/4885CYP1A2 2558/4885CYP1A1 3466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.